Tizanidine oral spray - NovaDel Pharma

Drug Profile

Tizanidine oral spray - NovaDel Pharma

Alternative Names: NVD-422

Latest Information Update: 11 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NovaDel Pharma
  • Class Antispastics; Benzothiazoles; Imidazolines; Muscle relaxants; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Muscle spasticity

Most Recent Events

  • 09 Apr 2008 Efficacy, pharmacokinetic and adverse events data from a pilot phase I pharmacokinetic trial in Spasticity released by NovaDel Pharma
  • 13 Sep 2006 Preclinical trials in Spasticity in USA (Transmucosal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top